Nahdi shareholders authorize board to pay 2023 interim dividends

01/06/2023 Argaam
Logo ofNahdi Medical Co.

Logo of Nahdi Medical Co.

Nahdi Medical Co.’s shareholders approved authorizing the board of directors to pay interim dividends for 2023 on a semi-annual or a quarterly basis during the extraordinary general meeting (EGM) held on May 31.  

 

In a statement to Tadawul, the company pointed out that shareholders also approved the businesses and contracts between Nahdi and Ray Medical Co., in which Chairman Saleh Mahfouz has an indirect interest. The deal is an agreement to provide medical analysis services to the company, noting that the annual value of transactions for 2023 is SAR 1 million.  

  

The contract concluded between Nahdi and Al Rajhi Banking Investment Co., in which the board member Abdullatif Al Saif, has an indirect interest, was also approved. The contract is an agreement to exchange services on points gained from both companies’ loyalty programs. The value of transactions for 2022 stood at SAR 24 million. 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.